# Effect of Immediate Hemoglobin A1c on Glycemic Control in Children With Type I Diabetes Mellitus

> **NCT00898534** · PHASE4 · COMPLETED · sponsor: **Boston Children's Hospital** · enrollment: 234 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus
- Glycemic Control

## Interventions

- **DEVICE:** Bayer DCA2000+ Hemoglobin A1c analyzer

## Key facts

- **NCT ID:** NCT00898534
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2005-09
- **Final completion:** 2006-01
- **Target enrollment:** 234 (ACTUAL)
- **Last updated:** 2009-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00898534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00898534, "Effect of Immediate Hemoglobin A1c on Glycemic Control in Children With Type I Diabetes Mellitus". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00898534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
